Drug Description in Trials / DrugBank / KEGG DRUG /

Search results

descriptions per page:

Showing 1 to 10 of 33 descriptions

Filter by

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	指定難病告示番号
1	Active BMN 111: Subcutaneous injection of recommended dose of BMN 111 based on weight-band dosing on ...	-	-	-	-	1件: 276
2	BGJ398 (also known as BBP-831)	-	-	-	-	1件: 276
3	BMN 111	-	-	-	-	1件: 276
4	C-type natriuretic peptide conjugated to a multi-arm polyethylene glycol carrier molecule through a ...	1件: Polyethylene glycol	1件: D03370	-	-	1件: 276
5	C-TYPE NATRIURETIC PEPTIDE CONJUGATED TO MULTI-ARM POLYETHYLENE GLYCOL CARRIER THROUGH A CLEAVABLE L ...	1件: Polyethylene glycol	1件: D03370	-	-	1件: 276
6	Growth hormone	1件: Somatotropin	-	-	-	14件: 2, 13, 19, 46, 78, 96, 107, 187, 191, 193, 195, 265, 276, 299
7	Human Growth Hormone	1件: Somatotropin	-	-	-	5件: 78, 187, 193, 265, 276
8	INFIGRATINIB	1件: Infigratinib	1件: D11589	3件: FGFR1, FGFR2, FGFR3 💬	21件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon met ...	1件: 276
9	Infigratinib 0.016 mg/kg	1件: Infigratinib	1件: D11589	3件: FGFR1, FGFR2, FGFR3 💬	21件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon met ...	1件: 276
10	Infigratinib 0.032 mg/kg	1件: Infigratinib	1件: D11589	3件: FGFR1, FGFR2, FGFR3 💬	21件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon met ...	1件: 276

First Previous1 2 3 4Next Last